SCREEN-ERR is a service designed to help companies evaluate multiple pharmaceutical trademark candidates at an early phase of trademark development. Once preliminary legal screening has taken place, SCREEN-ERR can determine whether any regulatory or other concerns exist which may result in a name deemed unacceptable to regulatory health authorities. It can be performed using global information resources, but SCREEN-ERR can be tailored to specific territories of interest.

SCREEN-ERR looks for obvious and potential regulatory conflicts. It is not intended to replace or supercede the ERRS MODEL^®  of safety testing, which incorporates a different range of criteria such as handwritten and verbal confusability of trademarks. It does consider each trademark candidate, providing a "green-yellow-red" rating of acceptability.

For our clients, SCREEN-ERR offers an efficient way to identify unacceptable candidates,  saving both time and money.